Kevin Bowman

Kevin Bowman is a seasoned scientist with over 20 years of experience in advancing drug discovery and development, currently serving as the Director of DMPK at Nuvation Bio since October 2021. Kevin has a strong background in drug metabolism and pharmacokinetics (DMPK), focusing on characterizing and optimizing the ADME properties of drug candidates. Prior experience includes serving as Principal Investigator in DMPK at Incyte from May 2005 to October 2021, where Kevin designed and executed in vitro and in vivo ADME/PK studies across multiple therapeutic areas. Early career experience includes working as an Associate Scientist at Charles River Laboratories, where Kevin conducted analytical validation for various in vitro ADMET assays. Kevin holds a Bachelor of Arts degree in Chemistry and Psychology from Rutgers University.